222 related articles for article (PubMed ID: 27075851)
1. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
Debeb BG; Lacerda L; Anfossi S; Diagaradjane P; Chu K; Bambhroliya A; Huo L; Wei C; Larson RA; Wolfe AR; Xu W; Smith DL; Li L; Ivan C; Allen PK; Wu W; Calin GA; Krishnamurthy S; Zhang XH; Buchholz TA; Ueno NT; Reuben JM; Woodward WA
J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075851
[TBL] [Abstract][Full Text] [Related]
2. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
3. microRNA-200c/141 upregulates SerpinB2 to promote breast cancer cell metastasis and reduce patient survival.
Jin T; Suk Kim H; Ki Choi S; Hye Hwang E; Woo J; Suk Ryu H; Kim K; Moon A; Kyung Moon W
Oncotarget; 2017 May; 8(20):32769-32782. PubMed ID: 28427146
[TBL] [Abstract][Full Text] [Related]
4. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
5. MiR-128 regulation of glucose metabolism and cell proliferation in triple-negative breast cancer.
Xiao M; Lou C; Xiao H; Yang Y; Cai X; Li C; Jia S; Huang Y
Br J Surg; 2018 Jan; 105(1):75-85. PubMed ID: 29116653
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
[TBL] [Abstract][Full Text] [Related]
7. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
[TBL] [Abstract][Full Text] [Related]
8. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-secreted miR-939 downregulates VE-cadherin and destroys the barrier function of endothelial monolayers.
Di Modica M; Regondi V; Sandri M; Iorio MV; Zanetti A; Tagliabue E; Casalini P; Triulzi T
Cancer Lett; 2017 Jan; 384():94-100. PubMed ID: 27693459
[TBL] [Abstract][Full Text] [Related]
10. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer.
D'Ippolito E; Plantamura I; Bongiovanni L; Casalini P; Baroni S; Piovan C; Orlandi R; Gualeni AV; Gloghini A; Rossini A; Cresta S; Tessari A; De Braud F; Di Leva G; Tripodo C; Iorio MV
Cancer Res; 2016 Sep; 76(18):5562-72. PubMed ID: 27402080
[TBL] [Abstract][Full Text] [Related]
11. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
[TBL] [Abstract][Full Text] [Related]
12. Pterostilbene inhibits triple-negative breast cancer metastasis via inducing microRNA-205 expression and negatively modulates epithelial-to-mesenchymal transition.
Su CM; Lee WH; Wu AT; Lin YK; Wang LS; Wu CH; Yeh CT
J Nutr Biochem; 2015 Jun; 26(6):675-85. PubMed ID: 25792283
[TBL] [Abstract][Full Text] [Related]
13. The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion.
Bogan D; Meile L; El Bastawisy A; Yousef HF; Zekri AN; Bahnassy AA; ElShamy WM
BMC Cancer; 2017 May; 17(1):329. PubMed ID: 28499366
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
15. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of brain metastases in women with breast cancer and p16 expression in metastatic lymph-nodes.
Furet E; El Bouchtaoui M; Feugeas JP; Miquel C; Leboeuf C; Beytout C; Bertheau P; Le Rhun E; Bonneterre J; Janin A; Bousquet G
Oncotarget; 2017 Jun; 8(23):37332-37341. PubMed ID: 28445153
[TBL] [Abstract][Full Text] [Related]
17. High serum miR-19a levels are associated with inflammatory breast cancer and are predictive of favorable clinical outcome in patients with metastatic HER2+ inflammatory breast cancer.
Anfossi S; Giordano A; Gao H; Cohen EN; Tin S; Wu Q; Garza RJ; Debeb BG; Alvarez RH; Valero V; Hortobagyi GN; Calin GA; Ueno NT; Woodward WA; Reuben JM
PLoS One; 2014; 9(1):e83113. PubMed ID: 24416156
[TBL] [Abstract][Full Text] [Related]
18. Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.
Eichelser C; Flesch-Janys D; Chang-Claude J; Pantel K; Schwarzenbach H
Clin Chem; 2013 Oct; 59(10):1489-96. PubMed ID: 23748853
[TBL] [Abstract][Full Text] [Related]
19. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
